[go: up one dir, main page]

WO2004005220A3 - Procede de resolution asymetrique d'un racemique faisant intervenir 2,3:4,6-di-o-isopropyilidene-2-keto-l-gulonique - Google Patents

Procede de resolution asymetrique d'un racemique faisant intervenir 2,3:4,6-di-o-isopropyilidene-2-keto-l-gulonique Download PDF

Info

Publication number
WO2004005220A3
WO2004005220A3 PCT/FR2003/002086 FR0302086W WO2004005220A3 WO 2004005220 A3 WO2004005220 A3 WO 2004005220A3 FR 0302086 W FR0302086 W FR 0302086W WO 2004005220 A3 WO2004005220 A3 WO 2004005220A3
Authority
WO
WIPO (PCT)
Prior art keywords
acid
racemic
asymmetric resolution
diprogulic
asymmetric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2003/002086
Other languages
English (en)
Other versions
WO2004005220A2 (fr
Inventor
Sonia Roussiasse
Stephane Frein
Alain Burgos
Blandine Bertrand
Myriam Clementz
Aline Total
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zach System SA
Original Assignee
PPG Sipsy SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PPG Sipsy SAS filed Critical PPG Sipsy SAS
Priority to AU2003263264A priority Critical patent/AU2003263264A1/en
Publication of WO2004005220A2 publication Critical patent/WO2004005220A2/fr
Publication of WO2004005220A3 publication Critical patent/WO2004005220A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procédé de résolution d'un racémique pour l'obtention d'un isomère optiquement actif caractérisé en ce que l'on fait réagir, avec de l'acide diprogulique ou un sel de cet acide, un racémique de formule générale (I) ci-dessous. Dans laquelle, Ar est un groupement hétéroaryl R1 est un groupement alkyl R 2 et R3, identiques ou différents, représentent chacun un atome d'hydrogène ou un groupement alkyl ; n est un entier compris entre 0 et 4.
PCT/FR2003/002086 2002-07-05 2003-07-04 Procede de resolution asymetrique d'un racemique faisant intervenir 2,3:4,6-di-o-isopropyilidene-2-keto-l-gulonique Ceased WO2004005220A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003263264A AU2003263264A1 (en) 2002-07-05 2003-07-04 Method for asymmetric resolution of a racemic using diprogulic acid and use of said acid as asymmetric resolution agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR02/08516 2002-07-05
FR0208516A FR2841899A1 (fr) 2002-07-05 2002-07-05 Procede de resolution asymetrique d'un racemique faisant intervenir l'acide diprogulique et utilisation dudit acide comme agent de resolution asymetrique

Publications (2)

Publication Number Publication Date
WO2004005220A2 WO2004005220A2 (fr) 2004-01-15
WO2004005220A3 true WO2004005220A3 (fr) 2004-04-15

Family

ID=29725239

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/002086 Ceased WO2004005220A2 (fr) 2002-07-05 2003-07-04 Procede de resolution asymetrique d'un racemique faisant intervenir 2,3:4,6-di-o-isopropyilidene-2-keto-l-gulonique

Country Status (3)

Country Link
AU (1) AU2003263264A1 (fr)
FR (1) FR2841899A1 (fr)
WO (1) WO2004005220A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ549381A (en) 2004-02-19 2010-05-28 Lonza Ag Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
WO2008004191A2 (fr) 2006-07-03 2008-01-10 Ranbaxy Laboratories Limited Procédé de préparation de duloxétine et de ses sels
US10012993B1 (en) 2016-12-09 2018-07-03 Zendrive, Inc. Method and system for risk modeling in autonomous vehicles

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014772A1 (fr) * 1992-12-21 1994-07-07 Smithkline Beecham Plc Enantiomeres de derives du carbazole utilises comme agonistes similaires a la 5-ht1
EP0650965A1 (fr) * 1993-10-12 1995-05-03 Eli Lilly And Company Synthèse asymétrique de (S)-(+)-N,N-dimethyl-3-(1-naphtalényloxy)-3-(2-thiènyl)propénamine un produit intermédiaire pour la préparation de duloxetine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014772A1 (fr) * 1992-12-21 1994-07-07 Smithkline Beecham Plc Enantiomeres de derives du carbazole utilises comme agonistes similaires a la 5-ht1
EP0650965A1 (fr) * 1993-10-12 1995-05-03 Eli Lilly And Company Synthèse asymétrique de (S)-(+)-N,N-dimethyl-3-(1-naphtalényloxy)-3-(2-thiènyl)propénamine un produit intermédiaire pour la préparation de duloxetine

Also Published As

Publication number Publication date
FR2841899A1 (fr) 2004-01-09
WO2004005220A2 (fr) 2004-01-15
AU2003263264A8 (en) 2004-01-23
AU2003263264A1 (en) 2004-01-23

Similar Documents

Publication Publication Date Title
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
WO2001077107A8 (fr) Production et utilisation de composes heterocycliques
DK1613304T3 (da) DPP-IV-inhibitorer
MXPA04009476A (es) Compuestos de (tiazol-4,2-disustituidos-5-il)amina como inhibidores de la pde7.
DE50209545D1 (de) Flüssigkristallines medium
MXPA03009548A (es) Arilsulfonamidas como agentes antivirales.
WO2003035620A1 (fr) Compose bicyclique
NO20054787L (no) Indenderivater som farmasotiske midler
EP1741714A4 (fr) Composé hétérocylique et agent de tumeur anti-maligne contenant celui-ci comme ingrédient actif
UA96149C2 (en) Method for producing 4-oxoquinoline compound
DK1325923T3 (da) Cephem-forbindelser og ESBL-detekterende reagenser indeholdende disse
WO2001060822A8 (fr) Derives d'aminoacides et leur utilisation en tant qu'inhibiteurs de la nep, l'ace et l'ece
WO2004005220A3 (fr) Procede de resolution asymetrique d'un racemique faisant intervenir 2,3:4,6-di-o-isopropyilidene-2-keto-l-gulonique
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
WO2003080631A3 (fr) Inhibiteurs de plasma carboxypeptidase b
WO2002059089A3 (fr) Procede de preparation d'analogues d'indene heterocycliques
DE50311388D1 (de) Nicht-peptidische brs-3-agonisten
EE200300090A (et) Asendatud imidasopüridiinühendite valmistamise meetod
WO2003014094A3 (fr) Heterocyclylarylsulfonamides
DE602004009306D1 (de) 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern
EP1650195A4 (fr) Methode servant a inhiber la production d'osteopontine
WO2008069069A8 (fr) Composé amide, sel de celui-ci et inhibiteur de formation de biofilm ou décapant de biofilm utilisant ce composé
EP1484319A4 (fr) Thioester d'acide oligolactique en chaine
MXPA05013732A (es) Proceso para preparacion de sensibilizador de insulina y compuesto intermediario del mismo.
EP1473291A4 (fr) Procede de production de lactone

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP